In addition, the levels of TG, TC, and TNF-α reduced by 33.3%, 16.7%, and 39.8%, respectively, suggesting the potential value of quercetin in treating non-alcoholic fatty liver disease (NAFLD). This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.